Most Recent Additions

PDF

The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease.
Graham P. Pidgeon, Judith H. Harmey, Elaine Kay, Maureen Da Costa, Henry P. Redmond, and David J. Bouchier-Hayes

PDF

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.
Graham P. Pidgeon, Martin P. Barr, Judith H. Harmey, Deirdre A. Foley, and David J. Bouchier-Hayes

PDF

Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
Elizabeth M. Connolly, Judith H. Harmey, Tony O'Grady, Deirdre Foley, Graham Roche-Nagle, Elaine Kay, and David J. Bouchier-Hayes

PDF

Antimetastatic activity of a cyclooxygenase-2 inhibitor.
Graham Roche-Nagle, Elizabeth M. Connolly, Molly Eng, David J. Bouchier-Hayes, and Judith H. Harmey

PDF

A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.
Martin P. Barr, Anne Marie Byrne, Angela M. Duffy, Claire M. Condron, Marc Devocelle, Patrick Harriott, David J. Bouchier-Hayes, and Judith H. Harmey

PDF

Enhancing research quality and reporting: why the Journal of Comorbidity is now publishing study protocols
Susan M. Smith, Stewart W. Mercer, Jane Gunn, Marjan van den Akker, and Martin Fortin

PDF

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).
Anne Marie Byrne, David J. Bouchier-Hayes, and Judith H. Harmey

PDF

Risk prediction models to predict emergency hospital admission in community-dwelling adults: a systematic review.
Emma Wallace, Ellen Stuart, Niall Vaughan, Kathleen Bennett, Tom Fahey, and Susan M. Smith

PDF

Managing patients with multimorbidity in primary care.
Emma Wallace, Chris Salisbury, Bruce Guthrie, Cliona Lewis, Tom Fahey, and Susan M. Smith

*Updated as of 07/06/15.